Roles of the immune system in cancer: from tumor initiation to metastatic progression

The presence of inflammatory immune cells in human tumors raises a fundamental question in oncology: How do cancer cells avoid the destruction by immune attack? In principle, tumor development can be controlled by cytotoxic innate and adaptive immune cells; however, as the tumor develops from neopla...

Full description

Saved in:
Bibliographic Details
Published inGenes & development Vol. 32; no. 19-20; pp. 1267 - 1284
Main Authors Gonzalez, Hugo, Hagerling, Catharina, Werb, Zena
Format Journal Article
LanguageEnglish
Published United States Cold Springs Harbor Laboratory Press 01.10.2018
Cold Spring Harbor Laboratory Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The presence of inflammatory immune cells in human tumors raises a fundamental question in oncology: How do cancer cells avoid the destruction by immune attack? In principle, tumor development can be controlled by cytotoxic innate and adaptive immune cells; however, as the tumor develops from neoplastic tissue to clinically detectable tumors, cancer cells evolve different mechanisms that mimic peripheral immune tolerance in order to avoid tumoricidal attack. Here, we provide an update of recent accomplishments, unifying concepts, and future challenges to study tumor-associated immune cells, with an emphasis on metastatic carcinomas.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
AC02-05CH11231
USDOE Office of Science (SC)
Present address: Department of Clinical Genetics, Lund University, SE-221 85 Lund, Sweden.
ISSN:0890-9369
1549-5477
1549-5477
DOI:10.1101/gad.314617.118